GBCI
Glacier Bancorp, Inc.
GBCI's fundamentals are strong: revenue grew 33% and its operating margin rose 4 points to 34%. At 18x earnings, it's trading in line with its usual 19x. Analysts expect that strong growth to continue.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
GBCI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
GBCI's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like GBCI.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
GBCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $48.14 | — |
| Cheap | 15x | $41.07 | -15% |
| Current | 18x | $48.14 | — |
| Fair | 19x | $50.20 | +4.3% |
| Expensive | 24x | $63.13 | +31% |
Historical ranges are pointers, not guarantees.
GBCI's PE is in its fair range at 18x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
GBCI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
GBCI has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
GBCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.48 | +30% |
| Q3 2026 | $2.67 | +31% |
| Q2 2026 | $2.44 | +27% |
| Q1 2026 | $2.14 | +15% |
| Q4 2025 | $1.99 | +19% |
| Q3 2025 | $2.04 | +26% |
| Q2 2025 | $1.92 | +17% |
| Q1 2025 | $1.86 | +6.3% |
| Q4 2024 | $1.67 | -17% |
GBCI has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
GBCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $329.8M | +27% |
| Q2 2026 | $317.5M | +32% |
| Q1 2026 | $306.8M | +38% |
| Q4 2025 | $306.5M | +37% |
| Q3 2025 | $260.7M | +21% |
| Q2 2025 | $240.6M | +21% |
| Q1 2025 | $222.6M | +13% |
| Q4 2024 | $223M | +13% |
GBCI's revenue has grown year over year for nine quarters in a row: $330M last quarter, up 27% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | +7.6 points |
| Q2 2026 | 39% | +12 points |
| Q1 2026 | 33% | +4.1 points |
| Q4 2025 | 25% | -8.1 points |
| Q3 2025 | 33% | +3.8 points |
| Q2 2025 | 27% | -0.2 points |
| Q1 2025 | 29% | +10 points |
| Q4 2024 | 33% | +1.5 points |
GBCI has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
GBCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $149.8M | +43% |
| Q2 2026 | $111.7M | +40% |
| Q1 2026 | $74.4M | +59% |
| Q3 2025 | $104.8M | -30% |
| Q2 2025 | $79.5M | +27% |
| Q1 2025 | $46.8M | +$103.5M |
| Q3 2024 | $150.1M | +15% |
| Q2 2024 | $62.7M | -48% |
GBCI has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
GBCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +86.3K shares |
| 1 year | +10% | +11.8M shares |
| 3 years | +18% | +19.5M shares |
| 5 years | +36% | +34.8M shares |
| Available history | +48% | +42M shares |
GBCI has the edge over IREN on shareholder dilution, with a more favorable share count trend.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
GBCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 1.1x | Healthy |
| Q3 2025 | 2.4x | Moderate |
| Q2 2025 | 3.6x | Elevated |
| Q1 2025 | 4.7x | High |
| Q4 2024 | 6.5x | High |
GBCI has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like GBCI.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
GBCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.0 | Neutral |
| Stochastic | 66.4 | Neutral |
GBCI's weekly RSI is 53 (neutral) and its Stochastic is 66 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
GBCI PE vs Financial Services Sector
| Metric | GBCI | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 13x | 38% above |
| PE % | 39 | 63 | 24 pts below |
GBCI is trading at 18x earnings, a 38% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
GBCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $46.0 | 4.7% above |
| 20 week MA | $47.7 | 0.9% above |
| 50 week MA | $47.4 | 1.5% above |
| 100 week MA | $46.4 | 3.8% above |
| 200 week MA | $42.7 | 13% above |
GBCI has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
GBCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $45.9 | $45.9 | -0.1% |
| 2021 | $45.9 | $56.0 | +22% |
| 2022 | $56.0 | $49.3 | -12% |
| 2023 | $49.3 | $41.3 | -16% |
| 2024 | $41.3 | $50.3 | +22% |
| 2025 | $50.3 | $45.5 | -9.5% |
| 2026 YTD | $45.5 | $48.1 | +5.8% |
GBCI has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.